img

Global Swine Pseudorabies Vaccine Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Swine Pseudorabies Vaccine Market Insights, Forecast to 2034

Biological products for preventing pseudorabies in pigs
Global Swine Pseudorabies Vaccine market is expected to reach to US$ 591 million in 2024, with a positive growth of %, compared with US$ 568 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Swine Pseudorabies Vaccine industry is evaluated to reach US$ 752.1 million in 2029. The CAGR will be 4.1% during 2024 to 2029.
The growth and development of the swine industry, especially in regions with high pork consumption, has boosted the demand for porcine pseudorabies vaccine. As hog production expands to meet the growing demand for pork products, the need for effective disease prevention measures, including vaccination, becomes more important, which is driving the porcine pseudorabies vaccine market.
Report Covers
This report presents an overview of global Swine Pseudorabies Vaccine market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Swine Pseudorabies Vaccine market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Keqian Biology
Zybio
Jinyu Biology
Cahic
Pulike Biology
Hayao
Qilu Animal Protection
Dahuanong
Huapai Biotechnology
Sinopharm Animal Health
Tecon
Zoetis
Boehringer Ingelheim
Bayer
Segment by Type
Swine Pseudorabies Vaccine , Live
Swine Pseudorabies　Vaccine, Inactivated

Segment by Application


Farms
Individual

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Swine Pseudorabies Vaccine plant distribution, commercial date of Swine Pseudorabies Vaccine, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Swine Pseudorabies Vaccine introduction, etc. Swine Pseudorabies Vaccine Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Swine Pseudorabies Vaccine
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Swine Pseudorabies Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Swine Pseudorabies Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Swine Pseudorabies Vaccine , Live
1.2.3 Swine Pseudorabies　Vaccine, Inactivated
1.3 Market by Application
1.3.1 Global Swine Pseudorabies Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Farms
1.3.3 Individual
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Swine Pseudorabies Vaccine Sales Estimates and Forecasts 2018-2029
2.2 Global Swine Pseudorabies Vaccine Revenue by Region
2.2.1 Global Swine Pseudorabies Vaccine Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Swine Pseudorabies Vaccine Revenue by Region (2018-2024)
2.2.3 Global Swine Pseudorabies Vaccine Revenue by Region (2024-2029)
2.2.4 Global Swine Pseudorabies Vaccine Revenue Market Share by Region (2018-2029)
2.3 Global Swine Pseudorabies Vaccine Sales Estimates and Forecasts 2018-2029
2.4 Global Swine Pseudorabies Vaccine Sales by Region
2.4.1 Global Swine Pseudorabies Vaccine Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Swine Pseudorabies Vaccine Sales by Region (2018-2024)
2.4.3 Global Swine Pseudorabies Vaccine Sales by Region (2024-2029)
2.4.4 Global Swine Pseudorabies Vaccine Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Swine Pseudorabies Vaccine Sales by Manufacturers
3.1.1 Global Swine Pseudorabies Vaccine Sales by Manufacturers (2018-2024)
3.1.2 Global Swine Pseudorabies Vaccine Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Swine Pseudorabies Vaccine in 2022
3.2 Global Swine Pseudorabies Vaccine Revenue by Manufacturers
3.2.1 Global Swine Pseudorabies Vaccine Revenue by Manufacturers (2018-2024)
3.2.2 Global Swine Pseudorabies Vaccine Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Swine Pseudorabies Vaccine Revenue in 2022
3.3 Global Key Players of Swine Pseudorabies Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Swine Pseudorabies Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Swine Pseudorabies Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Swine Pseudorabies Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Swine Pseudorabies Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Swine Pseudorabies Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Swine Pseudorabies Vaccine Sales by Type
4.1.1 Global Swine Pseudorabies Vaccine Historical Sales by Type (2018-2024)
4.1.2 Global Swine Pseudorabies Vaccine Forecasted Sales by Type (2024-2029)
4.1.3 Global Swine Pseudorabies Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Swine Pseudorabies Vaccine Revenue by Type
4.2.1 Global Swine Pseudorabies Vaccine Historical Revenue by Type (2018-2024)
4.2.2 Global Swine Pseudorabies Vaccine Forecasted Revenue by Type (2024-2029)
4.2.3 Global Swine Pseudorabies Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Swine Pseudorabies Vaccine Price by Type
4.3.1 Global Swine Pseudorabies Vaccine Price by Type (2018-2024)
4.3.2 Global Swine Pseudorabies Vaccine Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Swine Pseudorabies Vaccine Sales by Application
5.1.1 Global Swine Pseudorabies Vaccine Historical Sales by Application (2018-2024)
5.1.2 Global Swine Pseudorabies Vaccine Forecasted Sales by Application (2024-2029)
5.1.3 Global Swine Pseudorabies Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Swine Pseudorabies Vaccine Revenue by Application
5.2.1 Global Swine Pseudorabies Vaccine Historical Revenue by Application (2018-2024)
5.2.2 Global Swine Pseudorabies Vaccine Forecasted Revenue by Application (2024-2029)
5.2.3 Global Swine Pseudorabies Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Swine Pseudorabies Vaccine Price by Application
5.3.1 Global Swine Pseudorabies Vaccine Price by Application (2018-2024)
5.3.2 Global Swine Pseudorabies Vaccine Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Swine Pseudorabies Vaccine Market Size by Type
6.1.1 US & Canada Swine Pseudorabies Vaccine Sales by Type (2018-2029)
6.1.2 US & Canada Swine Pseudorabies Vaccine Revenue by Type (2018-2029)
6.2 US & Canada Swine Pseudorabies Vaccine Market Size by Application
6.2.1 US & Canada Swine Pseudorabies Vaccine Sales by Application (2018-2029)
6.2.2 US & Canada Swine Pseudorabies Vaccine Revenue by Application (2018-2029)
6.3 US & Canada Swine Pseudorabies Vaccine Market Size by Country
6.3.1 US & Canada Swine Pseudorabies Vaccine Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Swine Pseudorabies Vaccine Sales by Country (2018-2029)
6.3.3 US & Canada Swine Pseudorabies Vaccine Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Swine Pseudorabies Vaccine Market Size by Type
7.1.1 Europe Swine Pseudorabies Vaccine Sales by Type (2018-2029)
7.1.2 Europe Swine Pseudorabies Vaccine Revenue by Type (2018-2029)
7.2 Europe Swine Pseudorabies Vaccine Market Size by Application
7.2.1 Europe Swine Pseudorabies Vaccine Sales by Application (2018-2029)
7.2.2 Europe Swine Pseudorabies Vaccine Revenue by Application (2018-2029)
7.3 Europe Swine Pseudorabies Vaccine Market Size by Country
7.3.1 Europe Swine Pseudorabies Vaccine Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Swine Pseudorabies Vaccine Sales by Country (2018-2029)
7.3.3 Europe Swine Pseudorabies Vaccine Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Swine Pseudorabies Vaccine Market Size
8.1.1 China Swine Pseudorabies Vaccine Sales (2018-2029)
8.1.2 China Swine Pseudorabies Vaccine Revenue (2018-2029)
8.2 China Swine Pseudorabies Vaccine Market Size by Application
8.2.1 China Swine Pseudorabies Vaccine Sales by Application (2018-2029)
8.2.2 China Swine Pseudorabies Vaccine Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Swine Pseudorabies Vaccine Market Size by Type
9.1.1 Asia Swine Pseudorabies Vaccine Sales by Type (2018-2029)
9.1.2 Asia Swine Pseudorabies Vaccine Revenue by Type (2018-2029)
9.2 Asia Swine Pseudorabies Vaccine Market Size by Application
9.2.1 Asia Swine Pseudorabies Vaccine Sales by Application (2018-2029)
9.2.2 Asia Swine Pseudorabies Vaccine Revenue by Application (2018-2029)
9.3 Asia Swine Pseudorabies Vaccine Sales by Region
9.3.1 Asia Swine Pseudorabies Vaccine Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Swine Pseudorabies Vaccine Revenue by Region (2018-2029)
9.3.3 Asia Swine Pseudorabies Vaccine Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Swine Pseudorabies Vaccine Market Size by Type
10.1.1 Middle East, Africa and Latin America Swine Pseudorabies Vaccine Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Swine Pseudorabies Vaccine Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Swine Pseudorabies Vaccine Market Size by Application
10.2.1 Middle East, Africa and Latin America Swine Pseudorabies Vaccine Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Swine Pseudorabies Vaccine Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Swine Pseudorabies Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America Swine Pseudorabies Vaccine Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Swine Pseudorabies Vaccine Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Swine Pseudorabies Vaccine Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Keqian Biology
11.1.1 Keqian Biology Company Information
11.1.2 Keqian Biology Overview
11.1.3 Keqian Biology Swine Pseudorabies Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Keqian Biology Swine Pseudorabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Keqian Biology Recent Developments
11.2 Zybio
11.2.1 Zybio Company Information
11.2.2 Zybio Overview
11.2.3 Zybio Swine Pseudorabies Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Zybio Swine Pseudorabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Zybio Recent Developments
11.3 Jinyu Biology
11.3.1 Jinyu Biology Company Information
11.3.2 Jinyu Biology Overview
11.3.3 Jinyu Biology Swine Pseudorabies Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Jinyu Biology Swine Pseudorabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Jinyu Biology Recent Developments
11.4 Cahic
11.4.1 Cahic Company Information
11.4.2 Cahic Overview
11.4.3 Cahic Swine Pseudorabies Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Cahic Swine Pseudorabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Cahic Recent Developments
11.5 Pulike Biology
11.5.1 Pulike Biology Company Information
11.5.2 Pulike Biology Overview
11.5.3 Pulike Biology Swine Pseudorabies Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Pulike Biology Swine Pseudorabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Pulike Biology Recent Developments
11.6 Hayao
11.6.1 Hayao Company Information
11.6.2 Hayao Overview
11.6.3 Hayao Swine Pseudorabies Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Hayao Swine Pseudorabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Hayao Recent Developments
11.7 Qilu Animal Protection
11.7.1 Qilu Animal Protection Company Information
11.7.2 Qilu Animal Protection Overview
11.7.3 Qilu Animal Protection Swine Pseudorabies Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Qilu Animal Protection Swine Pseudorabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Qilu Animal Protection Recent Developments
11.8 Dahuanong
11.8.1 Dahuanong Company Information
11.8.2 Dahuanong Overview
11.8.3 Dahuanong Swine Pseudorabies Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Dahuanong Swine Pseudorabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Dahuanong Recent Developments
11.9 Huapai Biotechnology
11.9.1 Huapai Biotechnology Company Information
11.9.2 Huapai Biotechnology Overview
11.9.3 Huapai Biotechnology Swine Pseudorabies Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Huapai Biotechnology Swine Pseudorabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Huapai Biotechnology Recent Developments
11.10 Sinopharm Animal Health
11.10.1 Sinopharm Animal Health Company Information
11.10.2 Sinopharm Animal Health Overview
11.10.3 Sinopharm Animal Health Swine Pseudorabies Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Sinopharm Animal Health Swine Pseudorabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Sinopharm Animal Health Recent Developments
11.11 Tecon
11.11.1 Tecon Company Information
11.11.2 Tecon Overview
11.11.3 Tecon Swine Pseudorabies Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Tecon Swine Pseudorabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Tecon Recent Developments
11.12 Zoetis
11.12.1 Zoetis Company Information
11.12.2 Zoetis Overview
11.12.3 Zoetis Swine Pseudorabies Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Zoetis Swine Pseudorabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Zoetis Recent Developments
11.13 Boehringer Ingelheim
11.13.1 Boehringer Ingelheim Company Information
11.13.2 Boehringer Ingelheim Overview
11.13.3 Boehringer Ingelheim Swine Pseudorabies Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Boehringer Ingelheim Swine Pseudorabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Boehringer Ingelheim Recent Developments
11.14 Bayer
11.14.1 Bayer Company Information
11.14.2 Bayer Overview
11.14.3 Bayer Swine Pseudorabies Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Bayer Swine Pseudorabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Bayer Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Swine Pseudorabies Vaccine Industry Chain Analysis
12.2 Swine Pseudorabies Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Swine Pseudorabies Vaccine Production Mode & Process
12.4 Swine Pseudorabies Vaccine Sales and Marketing
12.4.1 Swine Pseudorabies Vaccine Sales Channels
12.4.2 Swine Pseudorabies Vaccine Distributors
12.5 Swine Pseudorabies Vaccine Customers
13 Market Dynamics
13.1 Swine Pseudorabies Vaccine Industry Trends
13.2 Swine Pseudorabies Vaccine Market Drivers
13.3 Swine Pseudorabies Vaccine Market Challenges
13.4 Swine Pseudorabies Vaccine Market Restraints
14 Key Findings in The Global Swine Pseudorabies Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Swine Pseudorabies Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Swine Pseudorabies Vaccine , Live
Table 3. Major Manufacturers of Swine Pseudorabies　Vaccine, Inactivated
Table 4. Global Swine Pseudorabies Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Swine Pseudorabies Vaccine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Swine Pseudorabies Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Swine Pseudorabies Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Swine Pseudorabies Vaccine Revenue Market Share by Region (2018-2024)
Table 9. Global Swine Pseudorabies Vaccine Revenue Market Share by Region (2024-2029)
Table 10. Global Swine Pseudorabies Vaccine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Swine Pseudorabies Vaccine Sales by Region (2018-2024) & (Box)
Table 12. Global Swine Pseudorabies Vaccine Sales by Region (2024-2029) & (Box)
Table 13. Global Swine Pseudorabies Vaccine Sales Market Share by Region (2018-2024)
Table 14. Global Swine Pseudorabies Vaccine Sales Market Share by Region (2024-2029)
Table 15. Global Swine Pseudorabies Vaccine Sales by Manufacturers (2018-2024) & (Box)
Table 16. Global Swine Pseudorabies Vaccine Sales Share by Manufacturers (2018-2024)
Table 17. Global Swine Pseudorabies Vaccine Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Swine Pseudorabies Vaccine Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Swine Pseudorabies Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Swine Pseudorabies Vaccine Price by Manufacturers 2018-2024 (US$/Box)
Table 21. Global Swine Pseudorabies Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Swine Pseudorabies Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Swine Pseudorabies Vaccine as of 2022)
Table 23. Global Key Manufacturers of Swine Pseudorabies Vaccine, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Swine Pseudorabies Vaccine, Product Offered and Application
Table 25. Global Key Manufacturers of Swine Pseudorabies Vaccine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Swine Pseudorabies Vaccine Sales by Type (2018-2024) & (Box)
Table 28. Global Swine Pseudorabies Vaccine Sales by Type (2024-2029) & (Box)
Table 29. Global Swine Pseudorabies Vaccine Sales Share by Type (2018-2024)
Table 30. Global Swine Pseudorabies Vaccine Sales Share by Type (2024-2029)
Table 31. Global Swine Pseudorabies Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Swine Pseudorabies Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Swine Pseudorabies Vaccine Revenue Share by Type (2018-2024)
Table 34. Global Swine Pseudorabies Vaccine Revenue Share by Type (2024-2029)
Table 35. Swine Pseudorabies Vaccine Price by Type (2018-2024) & (US$/Box)
Table 36. Global Swine Pseudorabies Vaccine Price Forecast by Type (2024-2029) & (US$/Box)
Table 37. Global Swine Pseudorabies Vaccine Sales by Application (2018-2024) & (Box)
Table 38. Global Swine Pseudorabies Vaccine Sales by Application (2024-2029) & (Box)
Table 39. Global Swine Pseudorabies Vaccine Sales Share by Application (2018-2024)
Table 40. Global Swine Pseudorabies Vaccine Sales Share by Application (2024-2029)
Table 41. Global Swine Pseudorabies Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Swine Pseudorabies Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Swine Pseudorabies Vaccine Revenue Share by Application (2018-2024)
Table 44. Global Swine Pseudorabies Vaccine Revenue Share by Application (2024-2029)
Table 45. Swine Pseudorabies Vaccine Price by Application (2018-2024) & (US$/Box)
Table 46. Global Swine Pseudorabies Vaccine Price Forecast by Application (2024-2029) & (US$/Box)
Table 47. US & Canada Swine Pseudorabies Vaccine Sales by Type (2018-2024) & (Box)
Table 48. US & Canada Swine Pseudorabies Vaccine Sales by Type (2024-2029) & (Box)
Table 49. US & Canada Swine Pseudorabies Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Swine Pseudorabies Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Swine Pseudorabies Vaccine Sales by Application (2018-2024) & (Box)
Table 52. US & Canada Swine Pseudorabies Vaccine Sales by Application (2024-2029) & (Box)
Table 53. US & Canada Swine Pseudorabies Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Swine Pseudorabies Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Swine Pseudorabies Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Swine Pseudorabies Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Swine Pseudorabies Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Swine Pseudorabies Vaccine Sales by Country (2018-2024) & (Box)
Table 59. US & Canada Swine Pseudorabies Vaccine Sales by Country (2024-2029) & (Box)
Table 60. Europe Swine Pseudorabies Vaccine Sales by Type (2018-2024) & (Box)
Table 61. Europe Swine Pseudorabies Vaccine Sales by Type (2024-2029) & (Box)
Table 62. Europe Swine Pseudorabies Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Swine Pseudorabies Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Swine Pseudorabies Vaccine Sales by Application (2018-2024) & (Box)
Table 65. Europe Swine Pseudorabies Vaccine Sales by Application (2024-2029) & (Box)
Table 66. Europe Swine Pseudorabies Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Swine Pseudorabies Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Swine Pseudorabies Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Swine Pseudorabies Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Swine Pseudorabies Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Swine Pseudorabies Vaccine Sales by Country (2018-2024) & (Box)
Table 72. Europe Swine Pseudorabies Vaccine Sales by Country (2024-2029) & (Box)
Table 73. China Swine Pseudorabies Vaccine Sales by Type (2018-2024) & (Box)
Table 74. China Swine Pseudorabies Vaccine Sales by Type (2024-2029) & (Box)
Table 75. China Swine Pseudorabies Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Swine Pseudorabies Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Swine Pseudorabies Vaccine Sales by Application (2018-2024) & (Box)
Table 78. China Swine Pseudorabies Vaccine Sales by Application (2024-2029) & (Box)
Table 79. China Swine Pseudorabies Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Swine Pseudorabies Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Swine Pseudorabies Vaccine Sales by Type (2018-2024) & (Box)
Table 82. Asia Swine Pseudorabies Vaccine Sales by Type (2024-2029) & (Box)
Table 83. Asia Swine Pseudorabies Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Swine Pseudorabies Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Swine Pseudorabies Vaccine Sales by Application (2018-2024) & (Box)
Table 86. Asia Swine Pseudorabies Vaccine Sales by Application (2024-2029) & (Box)
Table 87. Asia Swine Pseudorabies Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Swine Pseudorabies Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Swine Pseudorabies Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Swine Pseudorabies Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Swine Pseudorabies Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Swine Pseudorabies Vaccine Sales by Region (2018-2024) & (Box)
Table 93. Asia Swine Pseudorabies Vaccine Sales by Region (2024-2029) & (Box)
Table 94. Middle East, Africa and Latin America Swine Pseudorabies Vaccine Sales by Type (2018-2024) & (Box)
Table 95. Middle East, Africa and Latin America Swine Pseudorabies Vaccine Sales by Type (2024-2029) & (Box)
Table 96. Middle East, Africa and Latin America Swine Pseudorabies Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Swine Pseudorabies Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Swine Pseudorabies Vaccine Sales by Application (2018-2024) & (Box)
Table 99. Middle East, Africa and Latin America Swine Pseudorabies Vaccine Sales by Application (2024-2029) & (Box)
Table 100. Middle East, Africa and Latin America Swine Pseudorabies Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Swine Pseudorabies Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Swine Pseudorabies Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Swine Pseudorabies Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Swine Pseudorabies Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Swine Pseudorabies Vaccine Sales by Country (2018-2024) & (Box)
Table 106. Middle East, Africa and Latin America Swine Pseudorabies Vaccine Sales by Country (2024-2029) & (Box)
Table 107. Keqian Biology Company Information
Table 108. Keqian Biology Description and Major Businesses
Table 109. Keqian Biology Swine Pseudorabies Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 110. Keqian Biology Swine Pseudorabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Keqian Biology Recent Developments
Table 112. Zybio Company Information
Table 113. Zybio Description and Major Businesses
Table 114. Zybio Swine Pseudorabies Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 115. Zybio Swine Pseudorabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Zybio Recent Developments
Table 117. Jinyu Biology Company Information
Table 118. Jinyu Biology Description and Major Businesses
Table 119. Jinyu Biology Swine Pseudorabies Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 120. Jinyu Biology Swine Pseudorabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Jinyu Biology Recent Developments
Table 122. Cahic Company Information
Table 123. Cahic Description and Major Businesses
Table 124. Cahic Swine Pseudorabies Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 125. Cahic Swine Pseudorabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Cahic Recent Developments
Table 127. Pulike Biology Company Information
Table 128. Pulike Biology Description and Major Businesses
Table 129. Pulike Biology Swine Pseudorabies Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 130. Pulike Biology Swine Pseudorabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Pulike Biology Recent Developments
Table 132. Hayao Company Information
Table 133. Hayao Description and Major Businesses
Table 134. Hayao Swine Pseudorabies Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 135. Hayao Swine Pseudorabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Hayao Recent Developments
Table 137. Qilu Animal Protection Company Information
Table 138. Qilu Animal Protection Description and Major Businesses
Table 139. Qilu Animal Protection Swine Pseudorabies Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 140. Qilu Animal Protection Swine Pseudorabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Qilu Animal Protection Recent Developments
Table 142. Dahuanong Company Information
Table 143. Dahuanong Description and Major Businesses
Table 144. Dahuanong Swine Pseudorabies Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 145. Dahuanong Swine Pseudorabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Dahuanong Recent Developments
Table 147. Huapai Biotechnology Company Information
Table 148. Huapai Biotechnology Description and Major Businesses
Table 149. Huapai Biotechnology Swine Pseudorabies Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 150. Huapai Biotechnology Swine Pseudorabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Huapai Biotechnology Recent Developments
Table 152. Sinopharm Animal Health Company Information
Table 153. Sinopharm Animal Health Description and Major Businesses
Table 154. Sinopharm Animal Health Swine Pseudorabies Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 155. Sinopharm Animal Health Swine Pseudorabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Sinopharm Animal Health Recent Developments
Table 157. Tecon Company Information
Table 158. Tecon Description and Major Businesses
Table 159. Tecon Swine Pseudorabies Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 160. Tecon Swine Pseudorabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Tecon Recent Developments
Table 162. Zoetis Company Information
Table 163. Zoetis Description and Major Businesses
Table 164. Zoetis Swine Pseudorabies Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 165. Zoetis Swine Pseudorabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Zoetis Recent Developments
Table 167. Boehringer Ingelheim Company Information
Table 168. Boehringer Ingelheim Description and Major Businesses
Table 169. Boehringer Ingelheim Swine Pseudorabies Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 170. Boehringer Ingelheim Swine Pseudorabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Boehringer Ingelheim Recent Developments
Table 172. Bayer Company Information
Table 173. Bayer Description and Major Businesses
Table 174. Bayer Swine Pseudorabies Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 175. Bayer Swine Pseudorabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Bayer Recent Developments
Table 177. Key Raw Materials Lists
Table 178. Raw Materials Key Suppliers Lists
Table 179. Swine Pseudorabies Vaccine Distributors List
Table 180. Swine Pseudorabies Vaccine Customers List
Table 181. Swine Pseudorabies Vaccine Market Trends
Table 182. Swine Pseudorabies Vaccine Market Drivers
Table 183. Swine Pseudorabies Vaccine Market Challenges
Table 184. Swine Pseudorabies Vaccine Market Restraints
Table 185. Research Programs/Design for This Report
Table 186. Key Data Information from Secondary Sources
Table 187. Key Data Information from Primary Sources
List of Figures
Figure 1. Swine Pseudorabies Vaccine Product Picture
Figure 2. Global Swine Pseudorabies Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Swine Pseudorabies Vaccine Market Share by Type in 2022 & 2029
Figure 4. Swine Pseudorabies Vaccine , Live Product Picture
Figure 5. Swine Pseudorabies　Vaccine, Inactivated Product Picture
Figure 6. Global Swine Pseudorabies Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Swine Pseudorabies Vaccine Market Share by Application in 2022 & 2029
Figure 8. Farms
Figure 9. Individual
Figure 10. Swine Pseudorabies Vaccine Report Years Considered
Figure 11. Global Swine Pseudorabies Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Swine Pseudorabies Vaccine Revenue 2018-2029 (US$ Million)
Figure 13. Global Swine Pseudorabies Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Swine Pseudorabies Vaccine Revenue Market Share by Region (2018-2029)
Figure 15. Global Swine Pseudorabies Vaccine Sales 2018-2029 ((Box)
Figure 16. Global Swine Pseudorabies Vaccine Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Swine Pseudorabies Vaccine Sales YoY (2018-2029) & (Box)
Figure 18. US & Canada Swine Pseudorabies Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Swine Pseudorabies Vaccine Sales YoY (2018-2029) & (Box)
Figure 20. Europe Swine Pseudorabies Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Swine Pseudorabies Vaccine Sales YoY (2018-2029) & (Box)
Figure 22. China Swine Pseudorabies Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Swine Pseudorabies Vaccine Sales YoY (2018-2029) & (Box)
Figure 24. Asia (excluding China) Swine Pseudorabies Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Swine Pseudorabies Vaccine Sales YoY (2018-2029) & (Box)
Figure 26. Middle East, Africa and Latin America Swine Pseudorabies Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Swine Pseudorabies Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Swine Pseudorabies Vaccine in the World: Market Share by Swine Pseudorabies Vaccine Revenue in 2022
Figure 29. Global Swine Pseudorabies Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Swine Pseudorabies Vaccine Sales Market Share by Type (2018-2029)
Figure 31. Global Swine Pseudorabies Vaccine Revenue Market Share by Type (2018-2029)
Figure 32. Global Swine Pseudorabies Vaccine Sales Market Share by Application (2018-2029)
Figure 33. Global Swine Pseudorabies Vaccine Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Swine Pseudorabies Vaccine Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Swine Pseudorabies Vaccine Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Swine Pseudorabies Vaccine Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Swine Pseudorabies Vaccine Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Swine Pseudorabies Vaccine Revenue Share by Country (2018-2029)
Figure 39. US & Canada Swine Pseudorabies Vaccine Sales Share by Country (2018-2029)
Figure 40. U.S. Swine Pseudorabies Vaccine Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Swine Pseudorabies Vaccine Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Swine Pseudorabies Vaccine Sales Market Share by Type (2018-2029)
Figure 43. Europe Swine Pseudorabies Vaccine Revenue Market Share by Type (2018-2029)
Figure 44. Europe Swine Pseudorabies Vaccine Sales Market Share by Application (2018-2029)
Figure 45. Europe Swine Pseudorabies Vaccine Revenue Market Share by Application (2018-2029)
Figure 46. Europe Swine Pseudorabies Vaccine Revenue Share by Country (2018-2029)
Figure 47. Europe Swine Pseudorabies Vaccine Sales Share by Country (2018-2029)
Figure 48. Germany Swine Pseudorabies Vaccine Revenue (2018-2029) & (US$ Million)
Figure 49. France Swine Pseudorabies Vaccine Revenue (2018-2029) & (US$ Million)
Figure 50. U.K. Swine Pseudorabies Vaccine Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Swine Pseudorabies Vaccine Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Swine Pseudorabies Vaccine Revenue (2018-2029) & (US$ Million)
Figure 53. China Swine Pseudorabies Vaccine Sales Market Share by Type (2018-2029)
Figure 54. China Swine Pseudorabies Vaccine Revenue Market Share by Type (2018-2029)
Figure 55. China Swine Pseudorabies Vaccine Sales Market Share by Application (2018-2029)
Figure 56. China Swine Pseudorabies Vaccine Revenue Market Share by Application (2018-2029)
Figure 57. Asia Swine Pseudorabies Vaccine Sales Market Share by Type (2018-2029)
Figure 58. Asia Swine Pseudorabies Vaccine Revenue Market Share by Type (2018-2029)
Figure 59. Asia Swine Pseudorabies Vaccine Sales Market Share by Application (2018-2029)
Figure 60. Asia Swine Pseudorabies Vaccine Revenue Market Share by Application (2018-2029)
Figure 61. Asia Swine Pseudorabies Vaccine Revenue Share by Region (2018-2029)
Figure 62. Asia Swine Pseudorabies Vaccine Sales Share by Region (2018-2029)
Figure 63. Japan Swine Pseudorabies Vaccine Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Swine Pseudorabies Vaccine Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Swine Pseudorabies Vaccine Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Swine Pseudorabies Vaccine Revenue (2018-2029) & (US$ Million)
Figure 67. India Swine Pseudorabies Vaccine Revenue (2018-2029) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Swine Pseudorabies Vaccine Sales Market Share by Type (2018-2029)
Figure 69. Middle East, Africa and Latin America Swine Pseudorabies Vaccine Revenue Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Swine Pseudorabies Vaccine Sales Market Share by Application (2018-2029)
Figure 71. Middle East, Africa and Latin America Swine Pseudorabies Vaccine Revenue Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Swine Pseudorabies Vaccine Revenue Share by Country (2018-2029)
Figure 73. Middle East, Africa and Latin America Swine Pseudorabies Vaccine Sales Share by Country (2018-2029)
Figure 74. Brazil Swine Pseudorabies Vaccine Revenue (2018-2029) & (US$ Million)
Figure 75. Mexico Swine Pseudorabies Vaccine Revenue (2018-2029) & (US$ Million)
Figure 76. Turkey Swine Pseudorabies Vaccine Revenue (2018-2029) & (US$ Million)
Figure 77. Israel Swine Pseudorabies Vaccine Revenue (2018-2029) & (US$ Million)
Figure 78. GCC Countries Swine Pseudorabies Vaccine Revenue (2018-2029) & (US$ Million)
Figure 79. Swine Pseudorabies Vaccine Value Chain
Figure 80. Swine Pseudorabies Vaccine Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries